RDY 257 (Ziprasidone hydrochloride 40 mg)
Pill imprint RDY 257 has been identified as Ziprasidone hydrochloride 40 mg.
Ziprasidone is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; autism; obsessive compulsive disorder (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Ziprasidone 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 257
- Strength:
- 40 mg
- Color:
- Purple / Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy's Laboratories Limited
- National Drug Code (NDC):
- 55111-0257
- Inactive Ingredients:
- lactose anhydrous
magnesium stearate
polysorbate 80
povidone k30
corn starch
silicon dioxide
FD&C Blue No. 1
FD&C Red No. 3
gelatin
ferric oxide red
titanium dioxide
ferrosoferric oxide
butyl alcohol
alcohol
isopropyl alcohol
potassium hydroxide
propylene glycol
shellac
ammonia
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-6270 | Major Pharmaceuticals |
| 63739-0005 | McKesson Packaging Services |
Note: Inactive ingredients may vary.
More about ziprasidone
Consumer resources
- Ziprasidone
- Ziprasidone capsules
- Ziprasidone (Advanced Reading)
- Ziprasidone Intramuscular (Advanced Reading)
- Other brands: Geodon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
